Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
American Journal of Preventive Medicine
|
December 1, 2012
A role for research: an observation on preventive services for women
Natalia Olchanski, Joshua T Cohen, Peter J Neumann
Infection Control and Hospital Epidemiology
|
April 5, 2011
Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin-resistant Staphylococcus aureus screening programs in US hospitals
Natalia Olchanski, Charles Mathews, Lauren Fusfeld, et al.
International Journal of Cardiology
|
November 22, 2019
Two-year outcomes and cost for heart failure patients following discharge from the hospital after an acute heart failure admission
Natalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Cardiovascular Endocrinology & Metabolism
|
February 28, 2020
Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes
Natalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 8, 2025
Estimating the Risk-Based Value of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world?
Natalia Olchanski, Samuel B Weidner, Ching-Hsuan Lin, et al.
The American Journal of Managed Care
|
October 9, 2014
Potential role of network meta-analysis in value-based insurance design
James D Chambers, Aaron Winn, Yue Zhong, et al.
Hospital Practice (1995)
|
November 12, 2010
Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital
Natalia Olchanski, Katherine A Slawsky, Stephanie Plent, et al.
International Journal of Cardiology
|
April 17, 2018
Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions
Natalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 23, 2022
When are breakthrough therapies cost-effective?
Natalia Olchanski, Pei-Jung Lin, Wei-Shi Yeh, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 20, 2015
The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology
Natalia Olchanski, Yue Zhong, Joshua T Cohen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
American Journal of Preventive Medicine
|
December 1, 2012
A role for research: an observation on preventive services for women
Natalia Olchanski, Joshua T Cohen, Peter J Neumann
Infection Control and Hospital Epidemiology
|
April 5, 2011
Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin-resistant Staphylococcus aureus screening programs in US hospitals
Natalia Olchanski, Charles Mathews, Lauren Fusfeld, et al.
International Journal of Cardiology
|
November 22, 2019
Two-year outcomes and cost for heart failure patients following discharge from the hospital after an acute heart failure admission
Natalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Cardiovascular Endocrinology & Metabolism
|
February 28, 2020
Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes
Natalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 8, 2025
Estimating the Risk-Based Value of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world?
Natalia Olchanski, Samuel B Weidner, Ching-Hsuan Lin, et al.
The American Journal of Managed Care
|
October 9, 2014
Potential role of network meta-analysis in value-based insurance design
James D Chambers, Aaron Winn, Yue Zhong, et al.
Hospital Practice (1995)
|
November 12, 2010
Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital
Natalia Olchanski, Katherine A Slawsky, Stephanie Plent, et al.
International Journal of Cardiology
|
April 17, 2018
Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions
Natalia Olchanski, Amanda R Vest, Joshua T Cohen, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 23, 2022
When are breakthrough therapies cost-effective?
Natalia Olchanski, Pei-Jung Lin, Wei-Shi Yeh, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 20, 2015
The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology
Natalia Olchanski, Yue Zhong, Joshua T Cohen, et al.
Page
of 3